Med Monatsschr Pharm 2006 Apr;29(4):139-41
Klinische Pharmazie und Pharmakotherapie, Heinrich-Heine-Universität Düsseldorf.
Allogeneic hematopoetic stem cell transplantations can be complicated by a graft-versus-host disease (GvHD), i.e., immunocompetent cells from the transplanted bone marrow act against solid organs of the recipient. A GvHD is treated with immunosuppressants. Consequently, further drugs are required, for example in order to prevent infections and result in in polymedication of those patients with a risk of drug interactions. In this case report, drug interactions between tacrolimus and concomitant therapy in a stem-cell-transplanted patient are discussed.
Download full-text PDF